Comparison between Duroflex IPO and Yashoda Healthcare IPO.
Duroflex IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Yashoda Healthcare IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Duroflex IPO | Yashoda Healthcare IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Motilal Oswal Investment Advisors Ltd. JM Financial Ltd. | JM Financial Ltd. |
| Registrar | Kfin Technologies Ltd. | |
| Market Maker | ||
| DRHP | DRHP  | |
| RHP | ||
| Final Prospectus | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Duroflex IPO is up to ₹0.00 Cr whereas the issue size of the Yashoda Healthcare IPO is up to ₹0.00 Cr. The final issue price of Duroflex IPO is and of Yashoda Healthcare IPO is .
| Duroflex IPO | Yashoda Healthcare IPO | |
|---|---|---|
| Face Value | ₹1 per share | |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹183.60 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 2,25,64,569 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Duroflex IPO opens on , while Yashoda Healthcare IPO opens on . The closing date of Duroflex IPO and Yashoda Healthcare IPO is , and , respectively.
Duroflex IPO P/E ratio is , as compared to Yashoda Healthcare IPO P/E ratio of .
| Duroflex IPO | Yashoda Healthcare IPO | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 66.10 | ||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 12.72 | ||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.90 | ||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 11.82 | ||||||||||||||||||||||||||||||||||||||||||||||
In the Duroflex IPO Retail Individual Investors (RII) are offered 0 shares while in Yashoda Healthcare IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Duroflex IPO and in Yashoda Healthcare IPO.
| Duroflex IPO | Yashoda Healthcare IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 0 shares | |
| NII | 0 shares | |
| RII | 0 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 0 shares |
Duroflex IPO subscribed in total, whereas Yashoda Healthcare IPO subscribed .
